Dyslipidemia
Oxford University Press Inc (Verlag)
978-0-19-974286-8 (ISBN)
As part of the Oxford American Cardiology Library, this practical handbook is designed to serve as a concise yet authoritative resource on diagnosing and treating dyslipidemia. The book is tailored to the needs of busy health care professionals treating patients in various clinical settings, and focuses on presenting essential information to clinicians who are at the forefront of the diagnosis and management of dyslipidemia. Featuring evidence-based, concise yet comprehensive discussion of key clinical concepts in addition to numerous figures, tables and illustrations, this pocket-sized handbook will serve as an invaluable guide to healthcare professionals.
Ragavendra R. Baliga, MD, MBA, FACC, FRCP, is Vice Chief & Assistant Division Director, and Professor of Internal r s1cine at The Ohio State University Medical Center in Columbus, Ohio. Christopher P. Cannon, MD, is Associate Professor of Medicine at Harvard Medical School and Associate Physician, Cardiovascular Division, at Brigham and Women's Hospital in Boston, Massachusetts.
Contributors ; 1. LDL Cholesterol ; 2. HDL Cholesterol ; 3. Non-HDL Cholesterol ; 4. Use of High Sensitivity C-reactive Protein for Risk Assessment ; 5. Advanced Lipoprotein Testing: Assessment of Cardiovascular Risk and Therapy Beyond Standard Lipid Measurements ; 6. Stratification of Dyslipidemic Risk ; 7. Drugs for Treatment of Blood Lipoprotein Abnormalities ; Index
Erscheint lt. Verlag | 15.12.2011 |
---|---|
Reihe/Serie | Oxford American Cardiology Library |
Verlagsort | New York |
Sprache | englisch |
Maße | 198 x 127 mm |
Gewicht | 187 g |
Themenwelt | Medizinische Fachgebiete ► Innere Medizin ► Kardiologie / Angiologie |
Studium ► 1. Studienabschnitt (Vorklinik) ► Biochemie / Molekularbiologie | |
ISBN-10 | 0-19-974286-3 / 0199742863 |
ISBN-13 | 978-0-19-974286-8 / 9780199742868 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
aus dem Bereich